![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1423-0267|229|4|195-202
ISSN: 0030-3755
Source: Ophthalmologica, Vol.229, Iss.4, 2013-04, pp. : 195-202
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ophthalmologica, Vol. 225, Iss. 4, 2011-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
How Prevalent is Macular Telangiectasia Type 2?
Ophthalmic Epidemiology, Vol. 19, Iss. 4, 2012-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Unusual Presentations of Type 2 Idiopathic Macular Telangiectasia
Ophthalmologica, Vol. 230, Iss. 3, 2013-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Intravitreal Bevacizumab for Type 2 Idiopathic Macular Telangiectasia
Ophthalmic Research, Vol. 49, Iss. 4, 2013-01 ,pp. :